Abstract
In the majority of the countries, specialization in psychiatry comprises a 4–6-year training program, but the number of hours declared as psychopharmacology teaching comprises only 20–40 h within a 5-year resident teaching program. This chapter presents the actual situation of psychopharmacology-pharmacopsychiatry training for specialization in psychiatry, and it proposes a curriculum and a learning catalogue. Indeed, among the rare instruments available, there is the curriculum of the American Society of Clinical Psychopharmacology (ASCP), but it is not widely introduced. The chapter also presents teaching forms and discusses the question about who should teach these disciplines and how both learning and teaching should then be evaluated. It is concluded that a curriculum should include 150–200 h of theoretical teaching in psychopharmacology-pharmacopsychiatry and contain additional 300–400 h centered on practical bedside teaching and provided by senior psychiatrists and other experienced colleagues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baldwin DS, Kosky N (2007) Off-label prescribing in psychiatric practice. Adv Psychiatr Treat 13(6):414–422
Baumann P, Spies M, Moller HJ, Kasper S, Bitter I, Laux G (2017) A proposal for a psychopharmacology-pharmacotherapy catalogue of learning objectives and a curriculum in Europe. World J Biol Psychiatry 18(1):29–38
Birkett D, Brosen K, Cascorbi I, Gustafsson LL, Maxwell S, Rago L, Rawlins M, Reidenberg M, Sjoqvist F, Smith T et al (2010) Clinical pharmacology in research, teaching and health care: considerations by IUPHAR, the International Union of Basic and Clinical Pharmacology. Basic Clin Pharmacol Toxicol 107(1):531–559
Blier P (2014) Rational site-directed pharmacotherapy for major depressive disorder. Int J Neuropsychopharmacol 17(7):997–1008
Breyer-Pfaff U, Baumann P, Müller H, Müller-Oerlinghausen B, Poser B, Rommelspacher H, Saletu B (1995a) The Association of Neuropsychopharmacology and Pharmacopsychiatry (AGNP): proposed issues for a residency’s training in psychopharmacology (part 1). Pharmacopsychiatry 28:108–112
Breyer-Pfaff U, Baumann P, Müller H, Müller-Oerlinghausen B, Poser B, Rommelspacher H, Saletu B (1995b) The Association of Neuropsychopharmacology and Pharmacopsychiatry (AGNP): proposed issues for a residency’s training in psychopharmacology (part 2). Pharmacopsychiatry 28:153–157
Brittlebank A, Hermans M, Bhugra D, Pinto da Costa M, Rojnic-Kuzman M, Fiorillo A, Kurimay T, Hanon C, Wasserman D, van der Gaag RJ (2016) Training in psychiatry throughout Europe. Eur Arch Psychiatry Clin Neurosci 266(2):155–164
Brunnauer A, Laux G (2013) The effects of most commonly prescribed second generation antidepressants on driving ability: a systematic review: 70th birthday Prof. Riederer. J Neural Transm 120(1):225–232
Buckley PF, Miller BJ, Lehrer DS, Castle DJ (2009) Psychiatric comorbidities and schizophrenia. Schizophr Bull 35(2):383–402
Chrisman AK, Enderlin HT, Landry KL, Colvin JS, DeJohn MR (2007) Teaching evidence-based medicine pediatric psychopharmacology: integrating psychopharmacologic treatment into the broad spectrum of care. Child Adolesc Psychiatr Clin N Am 16(1):165–181
Coverdale J, Balon R, Beresin EV, Louie AK, Tait GR, Goldsmith M, Roberts LW (2014) Teaching clinical neuroscience to psychiatry residents: model curricula. Acad Psychiatry 38(2):111–115
de Leon J (2016) Pharmacogenetic tests in psychiatry: from fear to failure to hype. J Clin Psychopharmacol 36(4):299–304
Deacon BJ (2013) The biomedical model of mental disorder: a critical analysis of its validity, utility, and effects on psychotherapy research. Clin Psychol Rev 33(7):846–861
Deligiannidis KM, Girgis RR, Lau A, Balon R, Zisook S (2012) Psychiatry resident/fellow-initiated and -designed multi-modal psychopharmacology curriculum for major depression. Acad Psychiatry 36(5):414–418
Dell’Osso B, Albert U, Atti AR, Carmassi C, Carra G, Cosci F, Del Vecchio V, Di Nicola M, Ferrari S, Goracci A et al (2015) Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatr Dis Treat 11:1885–1909
Diaz-Caneja CM, Espliego A, Parellada M, Arango C, Moreno C (2014) Polypharmacy with antidepressants in children and adolescents. Int J Neuropsychopharmacol 17(7):1063–1082
Dubovsky SL (2005) Who is teaching psychopharmacology? Who should be teaching psychopharmacology? Acad Psychiatry 29(2):155–161
Dubovsky SL, Kaye DL, Pristach CA, DelRegno P, Pessar L, Stiles K (2010) Can academic departments maintain industry relationships while promoting physician professionalism? Acad Med 85(1):68–73
Ellison JM (2005) Teaching collaboration between pharmacotherapist and psychotherapist. Acad Psychiatry 29(2):195–202
Fanoe S, Kristensen D, Fink-Jensen A, Jensen HK, Toft E, Nielsen J, Videbech P, Pehrson S, Bundgaard H (2014) Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management. Eur Heart J 35(20):1306–1315
Fibiger HC (2012) Psychiatry, the pharmaceutical industry, and the road to better therapeutics. Schizophr Bull 38(4):649–650
Fleischhacker WW, Uchida H (2014) Critical review of antipsychotic polypharmacy in the treatment of schizophrenia. Int J Neuropsychopharmacol 17(7):1083–1093
Fountoulakis KN, Moller HJ (2011) Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. Int J Neuropsychopharmacol 14(3):405–412
Giles LL, Martini DR (2016) Challenges and promises of pediatric psychopharmacology. Acad Pediatr 16(6):508–518
Glick ID, Rush AJ (2016) Tools to facilitate the teaching and enhance the practice of psychopharmacology. Asian J Psychiatr 19:21–22
Glick ID, Zisook S (2005) The challenge of teaching psychopharmacology in the new millennium: the role of curricula. Acad Psychiatry 29(2):134–140
Glick ID, Salzman C, Cohen BM, Klein DF, Moutier C, Nasrallah HA, Ongur D, Wang P, Zisook S (2007) Improving the pedagogy associated with the teaching of psychopharmacology. Acad Psychiatry 31(3):211–217
Glick I, Balon R, Citrome L, Deligiannidis K, Ellison J, Janowsky DS, Girgis R, Lydiard B, Madaan V, Osser D et al. (2012) Model psychopharmacology curriculum, 7th edn. For training directors and teachers of psychopharmacology in psychiatric residency programs. User’s Guide to the curriculum and table of contents: American Society of Clinical Pharmacology, Inc., p 130
Glick I, Balon R, Citrome L, Deligiannidis K, Ellison J, Madaan V, Osser D, Prabhakar D, Wang PW, Zisook S (2014) Model psychopharmacology curriculum for training directors and teachers of psychopharmacology in psychiatric residency programs. The American Society of Clinical Psychopharmacology, Inc.
Gray J (2013) The state of clinical pharmacology today. Clin Pharmacol Ther 93(3):231–232
Harrison PJ, Baldwin DS, Barnes TR, Burns T, Ebmeier KP, Ferrieer IN, Nutt DJ (2011) No psychiatry without psychopharmacology. Br J Psychiatry 199(4):263–265
Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C et al (2017) Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 51(1-02):e1
Ito H, Yamazumi S (2003) Common types of medication errors on long-term psychiatric care units. Int J Qual Health Care 15(3):207–212
Jayaram G, Doyle D, Steinwachs D, Samuels J (2011) Identifying and reducing medication errors in psychiatry: creating a culture of safety through the use of an adverse event reporting mechanism. J Psychiatr Pract 17(2):81–88
Julius RJ, Novitsky MA Jr, Dubin WR (2009) Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract 15(1):34–44
Juul D, Winstead DK, Sheiber SC (2005) Assessment of psychopharmacology on the American Board of Psychiatry and Neurology examinations. Acad Psychiatry 29(2):211–214
Keers RN, Williams SD, Vattakatuchery JJ, Brown P, Miller J, Prescott L, Ashcroft DM (2014) Prevalence, nature and predictors of prescribing errors in mental health hospitals: a prospective multicentre study. BMJ Open 4(9):e006084
Keijsers CJ, van Hensbergen L, Jacobs L, Brouwers JR, de Wildt DJ, ten Cate OT, Jansen PA (2012) Geriatric pharmacology and pharmacotherapy education for health professionals and students: a systematic review. Br J Clin Pharmacol 74(5):762–773
Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5(2):e45
Laux G (2014) Proposal for a model psychopharmacology curriculum for psychiatric residents in Germany. Psychopharmakotherapie 21(2):64–68
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100
Likic R, Maxwell SR (2009) Prevention of medication errors: teaching and training. Br J Clin Pharmacol 67(6):656–661
Loayza N, Crettol S, Riquier F, Eap CB (2012) Adherence to antidepressant treatment: what the doctor thinks and what the patient says. Pharmacopsychiatry 45(5):204–207
Lotz-Rambaldi W, Schafer I, ten Doesschate R, Hohagen F (2008) Specialist training in psychiatry in Europe – results of the UEMS-survey. Eur Psychiatry 23(3):157–168
Mallo CJ, Mintz DL (2013) Teaching all the evidence bases: reintegrating psychodynamic aspects of prescribing into psychopharmacology training. Psychodyn Psychiatry 41(1):13–37
Mann K, Rothschild JM, Keohane CA, Chu JA, Bates DW (2008) Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification. World J Biol Psychiatry 9(1):24–33
Mayer S, van der Gaag RJ, Dom G, Wassermann D, Gaebel W, Falkai P, Schule C, European Psychiatric A (2014) European Psychiatric Association (EPA) guidance on post-graduate psychiatric training in Europe. Eur Psychiatry 29(2):101–106
Members of Emerge EMERG, Agrawal A, Aronson JK, Britten N, Ferner RE, de Smet PA, Fialova D, Fitzgerald RJ, Likic R, Maxwell SR et al (2009) Medication errors: problems and recommendations from a consensus meeting. Br J Clin Pharmacol 67(6):592–598
Millan MJ (2014) On ‘polypharmacy’ and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal. Int J Neuropsychopharmacol 17(7):1009–1037
Mintz DL (2005) Teaching the prescriber’s role: the psychology of psychopharmacology. Acad Psychiatry 29(2):187–194
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097
Mohr P, Hoschl C, Volavka J (2012) Teaching critical appraisal of articles on psychopharmacology. Acad Psychiatry 36(2):114–117
Moller HJ, Seemuller F, Schennach-Wolff R, Stubner S, Ruther E, Grohmann R (2014) History, background, concepts and current use of comedication and polypharmacy in psychiatry. Int J Neuropsychopharmacol 17(7):983–996
Montenegro R (2002) WPA educational programs. World Psychiatry 1(3):190–191
Muzyk AJ, White CD, Kinghorn WA, Thrall GC (2013) A psychopharmacology course for psychiatry residents utilizing active-learning and residents-as-teachers to develop life-long learning skills. Acad Psychiatry 37(5):332–335
Naber D, Hohagen F (2008) Training in psychiatry and psychotherapy in Germany. Encéphale 34(2):107–109
Nutt D, Goodwin G (2011) ECNP Summit on the future of CNS drug research in Europe 2011: report prepared for ECNP by David Nutt and Guy Goodwin. Eur Neuropsychopharmacol 21(7):495–499
Oakley C, Malik A (2010) Psychiatric training in Europe. Psychiatrist 34:447–450
Peglow S, Spiegel D, Memon H, Briscoe G (2014) Big pharma in residency training: losing more than a free lunch? Acad Psychiatry 38(4):516–517
Perez DL, Torous J, Stern AP, Padmanabhan JL, Keshavan MS (2016) Response to “Tandon et al. Psychiatry is a clinical neuroscience, but how do we move the field”. Asian J Psychiatr 22:15–16
Prabhakar D, Balon R, Zisook S (2012) Assessing the need for a multi-modal curriculum in psychopharmacology education. Acad Psychiatry 36(6):497–499
Rakofsky JJ, Dunlop BW (2012) US psychiatric residents’ treatment of patients with bipolar disorder. J Clin Psychopharmacol 32(2):231–236
Riese F, Guloksuz S, Roventa C, Fair JD, Haravuori H, Rolko T, Flynn D, Giacco D, Banjac V, Jovanovic N et al (2015) Pharmaceutical industry interactions of psychiatric trainees from 20 European countries. Eur Psychiatry 30(2):284–290
Ross S, Loke YK (2009) Training good prescribers: what are the best methods? Clin Med (Lond) 9(5):478–480
Ross S, Maxwell S (2012) Prescribing and the core curriculum for tomorrow’s doctors: BPS curriculum in clinical pharmacology and prescribing for medical students. Br J Clin Pharmacol 74(4):644–661
Ryan C, Ross S, Davey P, Duncan EM, Francis JJ, Fielding S, Johnston M, Ker J, Lee AJ, MacLeod MJ et al (2014) Prevalence and causes of prescribing errors: the PRescribing Outcomes for Trainee Doctors Engaged in Clinical Training (PROTECT) study. PLoS One 9(1):e79802
Salzman C (2005) The limited role of expert guidelines in teaching psychopharmacology. Acad Psychiatry 29(2):176–179
Schildkrout B, Benjamin S, Lauterbach MD (2016) Integrating neuroscience knowledge and neuropsychiatric skills into psychiatry: the way forward. Acad Med 91(5):650–656
Shader RI (2016) The ten Cs of good clinical care. J Clin Psychopharmacol 36(5):413–414
Shore JH, Thurman MT, Fujinami L, Brooks E, Nagamoto H (2011) A resident, rural telepsychiatry service: training and improving care for rural populations. Acad Psychiatry 35(4):252–255
Sjoqvist F (2014) Development of clinical pharmacology as a medical speciality in Europe – the roles of WHO, IUPHAR and EACPT. Basic Clin Pharmacol Toxicol 115(2):172–178
Soerensen AL, Lisby M, Nielsen LP, Poulsen BK, Mainz J (2013) The medication process in a psychiatric hospital: are errors a potential threat to patient safety? Risk Manage Healthc Policy 6:23–31
Stahl SM (2016) Using neuroscience for naming psychotropic drugs. CNS Spectr 21(3):219–220
Strous RD (2011) Ethical considerations in clinical training, care and research in psychopharmacology. Int J Neuropsychopharmacol 14(3):413–424
Suzuki J, Ellison TV, Connery HS, Surber C, Renner JA (2016) Training in buprenorphine and office-based opioid treatment: a survey of psychiatry residency training programs. Acad Psychiatry 40(3):498–502
Tandon R, Rankupalli B, Suryadevara U, Thornton J (2015) Psychiatry is a clinical neuroscience, but how do we move the field? Asian J Psychiatr 17:135–137
Torous J, Stern AP, Padmanabhan JL, Keshavan MS, Perez DL (2015) A proposed solution to integrating cognitive-affective neuroscience and neuropsychiatry in psychiatry residency training: the time is now. Asian J Psychiatr 17:116–121
Vlastelica M (2013) Psychodynamic approach as a creative factor in psychopharmacotherapy. Psychiatr Danub 25(3):316–319
Weiden PJ, Rao N (2005) Teaching medication compliance to psychiatric residents: placing an orphan topic into a training curriculum. Acad Psychiatry 29(2):203–210
WHO (2005) World Health Organisation, World Psychiatric Association. Atlas Psychiatric Education and training across the world 2005. Geneva pp 1–44.
WPA (2002) World Psychiatric Association institutional program on the core training curriculum for psychiatry. Yokohama pp 1–90
Zisook S, Benjamin S, Balon R, Glick I, Louie A, Moutier C, Moyer T, Santos C, Servis M (2005) Alternate methods of teaching psychopharmacology. Acad Psychiatry 29(2):141–154
Zisook S, Balon R, Benjamin S, Beresin E, Goldberg DA, Jibson MD, Thrall G (2009) Psychopharmacology curriculum field test. Acad Psychiatry 33(5):358–363
Zohar J, Nutt DJ, Kupfer DJ, Moller HJ, Yamawaki S, Spedding M, Stahl SM (2014) A proposal for an updated neuropsychopharmacological nomenclature. Eur Neuropsychopharmacol 24:1005–1014
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Baumann, P. (2019). Training in Psychopharmacology-Pharmacopsychiatry for Residents in Psychiatry. In: Hermans, M., Chay-Hoon, T., Pi, E. (eds) Education about Mental Health and Illness. Mental Health and Illness Worldwide. Springer, Singapore. https://doi.org/10.1007/978-981-10-2350-7_9
Download citation
DOI: https://doi.org/10.1007/978-981-10-2350-7_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-2349-1
Online ISBN: 978-981-10-2350-7
eBook Packages: Behavioral Science and PsychologyReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences